Pharmacovigilance


SMi are proud to present the 3rd annual conference on Pharmacovigilance taking place on 1st & 2nd July 2013, London.

After recent Pharmacovigilance legislations, SMi’s conference will present the successes and failures since its implementation. 2012-2013 can be seen as year of significant change with regards to Pharmacovigilance practices and this topic has never been more of a focus for Pharmaceutical companies across the board.

With concerns occurring across the board in relation to PV auditing, companies face the challenge of understanding the key considerations when presenting to auditors. Unravel the challenges in compiling and presenting the new PSUR to external regulatory bodies and determine what these regulatory bodies have learnt in the wake of its recent introduction.

Visitors

SMi's RNA Therapeutics event is a must attend for the following:
Pharmacovigilance Team Leader
Drug Safety Officer
Global Drug Safety Officer
Pharmacogilance Manager
Head of Safety and Pharmacovigilance
Pharmacovigilance Consultants
International PV auditors
Senior Safety Specialist
QPPV personnel
Regulatory affairs Associates
Regulatory Affairs Manager
Lead Safety Scientist

Exhibitors

SMi offer sponsorship, advertising and branding packages, uniquely tailored to compliment your company's marketing strategy. Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. For further information please contact Alia Malick at amalick@smi-online.co.uk

Go to event website